MEDSTONE PHARMA LLC

MEDSTONE PHARMA LLC specializes in the manufacturing of sterile pharmaceutical preparations, with demonstrated expertise in the production of oral solid dosage forms, including branded and generic tablet formulations. The company’s technical capabilities center on cGMP-compliant manufacturing processes, regulatory documentation support, and end-to-end supply chain execution for controlled substances and specialty therapeutics. Their work includes precise formulation development, batch record management, and compliance with FDA and VA-specific pharmacovigilance requirements, particularly for migraine and neurologic indications such as zolmitriptan. The contractor’s operational focus reflects deep familiarity with complex drug submission protocols, including CRF reporting, label updates, and lifecycle management of FDA-approved products. The Department of Veterans Affairs is the sole federal agency with which MEDSTONE PHARMA LLC has established a contract relationship, indicating a targeted, mission-aligned partnership. The VA consistently engages the firm for the reliable, high-volume production of essential medications used in veteran care, particularly those requiring strict adherence to therapeutic equivalence and supply continuity standards. This recurring engagement suggests a trusted vendor status within VA’s pharmaceutical procurement ecosystem, where consistency, regulatory fidelity, and timely delivery are critical to patient outcomes. The company operates exclusively within NAICS 325412, reflecting a narrow but highly specialized focus on pharmaceutical preparation manufacturing. This vertical specialization positions MEDSTONE PHARMA LLC as a niche supplier of finished dosage forms rather than bulk active ingredients, serving the acute and chronic care needs of federal healthcare systems through precision compounding and quality-controlled production. As a 2L entity based in Weston, Florida, MEDSTONE PHARMA LLC is structured as a small business without federal certifications such as 8(a), HUBZone, or WOSB. Its geographic footprint is limited to its Florida facility, yet its market positioning is defined by its ability to meet stringent federal pharmaceutical standards, making it a dependable source for mission-critical drug products within the VA’s national formulary.